Volume 12, Number 4, April 2006

Economic Impact of Lyme Disease

Xinzhi Zhang,* Martin I. Meltzer,* César A. Peña,† Annette B. Hopkins,† Lane Wroth,‡ and Alan D. Fix†
*Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †University of Maryland, Baltimore, Maryland, USA; and ‡Care First-Easton Branch (previously Delmarva Health Plan), Easton, Maryland, USA

Figure 2. Distribution of elements of direct medical cost (US$) per Lyme disease (LD) patient in Maryland Eastern Shore (1997–2000). Mean is based on direct medical costs of LD patients. Direct medical costs were collected from medical record abstraction (1997–2000). Direct medical costs of LD included costs of physician visits, consultation, serologic tests, procedure, therapy, hospitalization/emergency room, and other relevant costs. All costs were converted to 2000 equivalent.

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed March 21, 2006

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention